Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Researchers are interested in determining whether it is safe to reduce anti-rejection medication by approximately 50% after liver transplantation and whether special blood tests called biomarkers can identify early signs that the body is starting to attack the new liver before it gets hurt.
Epistemonikos ID: 5dbd4eb7a851afd1ca652c5f097d09bce48eee13
First added on: Oct 08, 2026